528 material Form 8-K filings that 462 companies we cover made with the SEC in January 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Federated Hermes reported fourth-quarter 2024 diluted EPS of $1.04, up from $0.96 a year earlier, and full-year 2024 EPS of $3.23, down from $3.40. Full-year results include a $66.3 million non-cash impairment of an intangible asset recorded in Q2 2024, which the company said reduced EPS by $0.73. Total managed assets reached a record $829.6 billion at Dec. 31, 2024.
Q4 2024 net income was $84.7 million, compared with $82.2 million in Q4 2023.
Full-year 2024 net income was $268.3 million, compared with $299.0 million in 2023, including the $66.3 million impairment charge.
Total managed assets were $829.6 billion at Dec. 31, 2024, up 10% from $757.6 billion a year earlier.
The board declared a $0.31 quarterly dividend payable Feb. 14, 2025; the company bought back 552,533 Class B shares for $22.1 million in Q4 2024.
PennyMac Mortgage Investment Trust reported fourth-quarter 2024 net income attributable to common shareholders of $36.1 million, or $0.41 per diluted share, on net investment income of $107.9 million. For the full year, net income attributable to common shareholders fell to $119.2 million, or $1.37 per diluted share, from $157.8 million, or $1.63, in 2023.
Q4 2024 diluted EPS of $0.41, up from $0.36 in Q3 2024 but below $0.44 in Q4 2023
Full-year 2024 net investment income of $334.2 million, down from $429.0 million in 2023
Book value per common share rose to $15.87 at December 31, 2024, from $15.85 at September 30, 2024
Q4 2024 cash dividend of $0.40 per common share was paid on January 24, 2025
Xylem said its fourth-quarter and full-year 2024 results will be largely in line with or above its prior guidance, and that management committed on January 28, 2025 to a restructuring plan with workforce reductions across all businesses and functions. The company expects pre-tax charges of $95 million to $115 million, mostly in 2025, which will weigh on reported profit while the cuts aim to streamline the organization.
Q4 and full-year 2024 results expected to be largely in line with or above guidance given October 31, 2024
Restructuring committed January 28, 2025, with workforce reductions across all businesses and functions
Pre-tax charges of approximately $95 million to $115 million, primarily in 2025, including about $19 million in Q4 2024
Most workforce reductions expected in fiscal 2025, with some in 2026, subject to local laws
The Hartford reported fourth quarter 2024 net income available to common stockholders of $848 million ($2.88 per diluted share), up 11% from a year earlier, while core earnings of $865 million ($2.94 per diluted share) fell 7%. For full year 2024, net income rose 24% to $3.1 billion and core earnings rose 11% to $3.1 billion, and the company returned $2.1 billion to stockholders.
Q4 2024 net income available to common stockholders was $848 million ($2.88 per diluted share), up from $766 million in Q4 2023.
Q4 2024 core earnings were $865 million ($2.94 per diluted share), down from $935 million in Q4 2023.
Q4 2024 included a $203 million pre-tax charge for asbestos and environmental reserves, of which $62 million was ceded to the A&E retroactive reinsurance treaty, and a $58 million pre-tax benefit from the Navigators ADC deferred gain amorti
For full year 2024, net income was $3.1 billion ($10.35 per diluted share) and core earnings were $3.1 billion ($10.30 per diluted share).
VIAVI reported preliminary fiscal second-quarter results for the quarter ended December 28, 2024, with net revenue of $270.8 million, up 6.4% year over year. GAAP net income fell 15.0% to $9.1 million, while non-GAAP diluted EPS rose 18.2% to $0.13. The company also guided third-quarter net revenue to $276 million to $288 million and non-GAAP EPS to $0.10 to $0.13, and said the results are preliminary until it files its Form 10-Q.
Net revenue of $270.8 million, up $16.3 million or 6.4% year over year; Network Enablement revenue rose 15.1% to $179.0 million
GAAP diluted EPS of $0.04, down $0.01 or 20.0% year over year; non-GAAP diluted EPS of $0.13, up $0.02 or 18.2%
Third-quarter fiscal 2025 guidance: net revenue of $276 million to $288 million and non-GAAP EPS of $0.10 to $0.13
Acquisition of Inertial Labs, Inc. completed January 28, 2025; results remain preliminary pending the Form 10-Q
Kirby reported fourth quarter 2024 results. GAAP net earnings attributable to Kirby fell to $42.8 million, or $0.74 per share, from $61.9 million, or $1.04 per share, a year earlier, after a $56.3 million non-cash impairment charge. Excluding one-time items, adjusted earnings were $74.9 million, or $1.29 per share, and revenues rose slightly to $802.3 million, and the company expects 2025 earnings per share growth of 15% to 25%.
Q4 2024 GAAP EPS $0.74 vs. $1.04 in Q4 2023; adjusted EPS $1.29, up 24% year over year
Q4 revenues $802.3 million vs. $799.2 million in Q4 2023
$56.3 million non-cash impairment in Distribution and Services, mainly conventional diesel fracturing equipment inventory
2025 outlook: earnings per share growth of 15% to 25% year over year; operating cash flow of $620 million to $720 million
Berkshire Hills Bancorp reported fourth-quarter 2024 GAAP net income of $19.7 million, or $0.46 per share, down from $37.5 million, or $0.88 per share, in the prior quarter. Operating earnings rose 5% linked quarter to $26.0 million, or $0.60 per share, but GAAP results included $6.6 million in non-operating expenses related primarily to the pending merger with Brookline Bancorp.
Q4 2024 GAAP EPS $0.46 vs $0.88 in Q3 2024; operating EPS $0.60, up 3% linked quarter and 28% year over year
Total net revenue $110.2 million in Q4 2024 vs $125.6 million in Q3 2024 and $80.0 million in Q4 2023
FY2024 GAAP EPS $1.43 vs $1.60 in 2023; FY2024 operating EPS $2.22, up 4%
Management held a conference call on January 30, 2025 to discuss results and provide guidance; the filing does not state guidance figures
Cullen/Frost reported fourth-quarter 2024 net income available to common shareholders of $153.2 million, up from $100.9 million a year earlier, when results included a $51.5 million FDIC surcharge. For full-year 2024, net income available to common shareholders fell 2.6% to $575.9 million, and diluted EPS was $8.87 versus $9.10 in 2023. The board also authorized a $150 million share repurchase program running through January 28, 2026.
Q4 2024 net income available to common shareholders was $153.2 million, up $52.3 million from $100.9 million in Q4 2023
Q4 2024 diluted EPS was $2.36, compared with $1.55 in Q4 2023
Full-year 2024 net income available to common shareholders was $575.9 million, down 2.6% from $591.3 million in 2023
Board authorized up to $150 million in common stock repurchases through January 28, 2026, and declared a first-quarter dividend of $0.95 per common share payable March 14, 2025
Schneider National reported fourth-quarter 2024 operating revenues of $1.3 billion, down 2% from a year earlier, while income from operations rose 35% to $42.4 million and diluted EPS rose to $0.18 from $0.15. The company guided to 2025 adjusted diluted EPS of $0.90 to $1.20, but full-year 2024 net income fell to $117.0 million from $238.5 million.
Q4 2024 operating revenues were $1.3 billion versus $1.4 billion in Q4 2023; income from operations was $42.4 million versus $31.3 million.
Diluted EPS was $0.18 versus $0.15; adjusted diluted EPS was $0.20 versus $0.16.
Full-year 2024 net income was $117.0 million versus $238.5 million, and diluted EPS was $0.66 versus $1.34.
2025 guidance calls for adjusted diluted EPS of $0.90 to $1.20 and net capital expenditures of $400 million to $450 million; the quarter included about $7.0 million of claims reserve expense.
Darling Ingredients issued a statement on fourth quarter and fiscal 2024 results for its 50/50 Diamond Green Diesel (DGD) joint venture, whose figures were reported by its partner Valero. DGD's renewable diesel segment earned about $170 million in operating income in the quarter, but a lower of cost-or-market valuation adjustment of about $118 million reduced results, and the company's full-year 2024 figures also include a $176 million adjustment. The filing does not include consolidated revenue, earnings per share or 2025 guidance; the company will release full results and outlook on February 6, 2025.
DGD Q4 2024 EBITDA per gallon was $0.40, or $0.81 excluding the lower of cost-or-market adjustment
DGD full-year 2024 EBITDA per gallon was $0.46, or $0.60 excluding the adjustment
DGD sold or shipped 292.8 million gallons in Q4 2024 and 1.25 billion gallons for full-year 2024
Full fourth quarter and fiscal 2024 results and 2025 outlook are scheduled for release and a conference call on February 6, 2025
National Fuel Gas reported fiscal first-quarter 2025 results for the quarter ended December 31, 2024. GAAP net income fell to $45.0 million ($0.49 per share) from $133.0 million ($1.44 per share) after $104.6 million in after-tax impairment charges in its Exploration & Production segment, while adjusted operating results rose 14% to $151.9 million ($1.66 per share). The company raised its fiscal 2025 adjusted EPS guidance to $6.50 to $7.00 from $5.50 to $6.00, citing higher forecasted natural gas prices.
GAAP net income of $45.0 million, or $0.49 per share, versus $133.0 million, or $1.44 per share, a year earlier
Impairment charges of $104.6 million after tax, mainly a full cost ceiling test write-down at Seneca
Adjusted operating results of $151.9 million, or $1.66 per share, up 14% from the prior year
Fiscal 2025 adjusted EPS guidance raised to $6.50 to $7.00 from $5.50 to $6.00; NYMEX gas price assumption raised to $3.50 per MMBtu from $2.80
ManpowerGroup reported fourth-quarter 2024 revenue of $4.4 billion, down 5% as reported, and diluted EPS of $0.47 versus a loss of $1.73 a year earlier, which reflected large prior-year charges. Excluding restructuring, pension, and Austria-related charges, quarterly EPS was $1.02, down 27% in constant currency, and the company guided first-quarter 2025 diluted EPS to $0.47 to $0.57.
Q4 2024 revenue was $4.4 billion, down 5% as reported and down 3% in constant currency; net earnings were $22.5 million versus a net loss of $84.5 million a year earlier.
Full-year 2024 revenue was $17.9 billion, down 6%, while diluted EPS was $3.01 versus $1.76 in 2023; adjusted EPS was $4.55.
First-quarter 2025 diluted EPS is guided to $0.47 to $0.57, including an estimated 6 cents unfavorable currency impact and a 36% effective tax rate.
The company repurchased $34 million of common stock in the fourth quarter.
Parker Hannifin reported fiscal second-quarter 2025 results for the quarter ended December 31, 2024, with net sales of $4.74 billion, down from $4.82 billion a year earlier, while diluted EPS rose 39% to $7.25 on a reported basis. The company said the reported profit increase was helped by gains on divestitures, and adjusted EPS rose 6% to $6.53. The company also updated its fiscal 2025 guidance, which now calls for sales growth of (2%) to 1% and EPS of $24.46 to $25.06.
Net sales were $4.74 billion versus $4.82 billion a year earlier; organic sales growth was 1%.
Diluted EPS was $7.25 versus $5.23; adjusted EPS was $6.53 versus $6.15, up 6%.
Net income was $949 million, including a $249.7 million gain on divestitures in the quarter.
Fiscal 2025 guidance: sales growth of (2%) to 1% and EPS of $24.46 to $25.06, or $26.40 to $27.00 adjusted.
S&T Bancorp reported fourth-quarter 2024 net income of $33.1 million, or $0.86 per diluted share, up slightly from $32.6 million in the third quarter but down from $37.0 million, or $0.96 per share, a year earlier. For full year 2024, net income was $131.3 million, or $3.41 per diluted share, compared with $144.8 million, or $3.74, in 2023. The board also approved a quarterly dividend of $0.34 per share, up $0.01 from a year earlier.
Q4 2024 net income $33.1 million ($0.86 diluted EPS) vs. $32.6 million ($0.85) in Q3 2024 and $37.0 million ($0.96) in Q4 2023
Full year 2024 net income $131.3 million ($3.41 EPS) vs. $144.8 million ($3.74 EPS) in 2023
Q4 2024 net interest income $83.3 million, down $1.2 million from Q3 2024; total assets $9.7 billion at December 31, 2024
Dividend of $0.34 per share payable February 27, 2025 to shareholders of record on February 13, 2025
Tractor Supply reported fourth-quarter 2024 net sales up 3.1% to $3.77 billion, but diluted EPS fell 3.3% to $0.44 and net income fell 4.6%. For fiscal 2024, net sales rose 2.2% to $14.88 billion and diluted EPS rose 1.1% to $2.04, and the company guided to fiscal 2025 diluted EPS of $2.10 to $2.22 and net sales growth of 5% to 7%.
Q4 2024 net sales rose 3.1% to $3.77 billion; comparable store sales rose 0.6%.
Q4 2024 net income fell 4.6% to $236.4 million; diluted EPS was $0.44 versus $0.46 a year earlier.
Fiscal 2024 diluted EPS was $2.04, up from $2.02 in fiscal 2023.
Fiscal 2025 guidance: net sales up 5% to 7%, operating margin 9.6% to 10.0%, diluted EPS $2.10 to $2.22.
A. O. Smith reported full-year 2024 net sales of $3.8 billion, down 1%, and diluted EPS of $3.63, down 2%, with fourth-quarter EPS down 18%. The company also gave 2025 guidance of $3.60 to $3.90 in diluted EPS, a range it describes as slightly higher than 2024 at the midpoint, which shareholders will weigh against the weaker 2024 results.
Full-year 2024 net sales were $3.8 billion, down 1%, and net earnings were $533.6 million, down 4%.
Fourth-quarter 2024 net sales were $912.4 million, down 8%, and diluted EPS was $0.75, down 18% from $0.92.
2025 outlook projects net sales of $3.8 billion to $3.9 billion and diluted EPS of $3.60 to $3.90.
The board approved a $0.34 per share dividend payable February 18, 2025, and the company expects 2025 share repurchases of about $400 million.
Cardinal Health reported fiscal second-quarter 2025 revenue of $55.3 billion, down 4% from a year earlier, though revenue rose 16% excluding a previously communicated large customer contract expiration. Non-GAAP diluted EPS rose 2% to $1.93, and the company raised its fiscal 2025 non-GAAP EPS guidance to $7.85 to $8.00 while completing its majority acquisition of GI Alliance.
Q2 revenue $55.3 billion, down 4%; GAAP diluted EPS $1.65, up 10%; non-GAAP diluted EPS $1.93, up 2%
Fiscal 2025 non-GAAP EPS guidance raised to $7.85 to $8.00, from $7.75 to $7.90
Interest and other expense outlook raised to $200 million to $230 million, from $140 million to $170 million
GMPD segment profit guidance lowered to $130 million to $150 million, from $140 million to $175 million, due to a WaveMark receivables write-off
Asbury Automotive reported fourth quarter 2024 revenue of $4.5 billion, up 18%, and net income of $129 million, up from $56 million a year earlier. Adjusted net income fell 2% to $143 million, and full-year 2024 diluted EPS fell 25% to $21.50, so the results point in mixed directions for shareholders.
Q4 2024 total revenue of $4.5 billion, an increase of 18%; GAAP diluted EPS of $6.54 versus $2.70 in Q4 2023
Q4 2024 adjusted diluted EPS of $7.26 versus $7.12 in Q4 2023, a 2% decrease in adjusted net income to $143 million
Full-year 2024 net income of $430 million ($21.50 per diluted share) versus $603 million ($28.74) in 2023
Approximately 830,000 shares repurchased for $183 million in 2024; about $276 million remained on the authorization at December 31, 2024
Dover reported fourth quarter 2024 revenue of $1.9 billion, up 1%, while GAAP earnings from continuing operations fell 8% to $238 million. Adjusted diluted EPS rose 1% to $2.20, and the company guided 2025 adjusted EPS from continuing operations to $9.30 to $9.50 on 2% to 4% revenue growth.
Q4 2024 GAAP diluted EPS from continuing operations was $1.72, down 7% from $1.84; adjusted diluted EPS was $2.20, up 1%.
Full-year 2024 revenue was $7.7 billion, up 1%; GAAP diluted EPS from continuing operations was $10.09, up 50%, including a $597.8 million gain on dispositions.
2025 guidance: GAAP EPS from continuing operations of $8.16 to $8.36 and adjusted EPS of $9.30 to $9.50, based on revenue growth of 2% to 4%.
Management will discuss results on a webcast and conference call on January 30, 2025, at 9:00 a.m. Eastern Time.
Dow approved targeted cost actions, including a global workforce reduction of about 1,500 roles, to offset ongoing macroeconomic weakness. The company expects $250 million to $325 million in severance and related charges in the first quarter of 2025, plus $20 million to $30 million in implementation costs, with most of the $1 billion in targeted savings achieved on an annual run-rate basis.
Workforce reduction of approximately 1,500 roles globally, approved by the Board on January 27, 2025
Severance and related charges of $250 million to $325 million to be recorded in Q1 2025, with cash payments mostly over the next two years
Implementation costs of $20 million to $30 million, expensed as incurred
Targets $500 million to $700 million reduction in direct costs, mainly purchased services and third-party contract labor
The Cigna Group reported fourth quarter and full-year 2024 results on January 30, 2025. Full-year revenue rose 27% to $247.1 billion and adjusted income rose 4% to $7.7 billion, but fourth-quarter adjusted income fell 8% on higher stop loss medical costs at Cigna Healthcare, and GAAP net income fell to $3.4 billion from $5.2 billion after a $2.7 billion VillageMD impairment. The company projects 2025 adjusted income of at least $7.9 billion, or $29.50 per share, and raised its quarterly dividend 8% to $1.51 per share.
Q4 2024 shareholders' net income was $1.4 billion ($5.13 per share), versus $1.0 billion ($3.49 per share) in Q4 2023; Q4 adjusted income was $1.8 billion ($6.64 per share), versus $2.0 billion ($6.79 per share).
Full-year 2024 shareholders' net income of $3.4 billion ($12.12 per share) included a non-cash after-tax loss of $2.7 billion ($9.53 per share) tied to the VillageMD impairment.
2025 adjusted income from operations is projected at least $7.9 billion, or at least $29.50 per share.
Quarterly dividend raised 8% to $1.51 per share, payable March 20, 2025; total share repurchase authorization is $10.3 billion after a $6.0 billion increase.
UPS reported fourth-quarter 2024 revenue of $25.3 billion, up 1.5% from a year earlier, and diluted EPS of $2.01 on a GAAP basis, compared with $1.87 a year earlier. The company also forecast 2025 consolidated revenue of about $89.0 billion, below its $91.1 billion for 2024, and an operating margin of about 10.8%, after announcing an agreement in principle to cut volume from its largest customer by more than 50% by the second half of 2026.
Q4 2024 consolidated revenue was $25.3 billion, up 1.5%; operating profit was $2.9 billion, up 18.1%
GAAP diluted EPS was $2.01 versus $1.87 a year earlier; non-GAAP adjusted diluted EPS was $2.75 versus $2.47
2025 outlook: revenue of about $89.0 billion and operating margin of about 10.8%, versus full-year 2024 revenue of $91.1 billion
Efficiency Reimagined and network reconfiguration target about $1.0 billion in annualized savings; Q4 charges totaled $639 million, or $0.74 per diluted share
Flagstar Financial reported a fourth-quarter 2024 GAAP net loss attributable to common stockholders of $168 million, or $0.41 per diluted share, compared with $289 million, or $0.79 per share, in the third quarter of 2024. For the full year 2024, the net loss attributable to common stockholders was $1,125 million, or $3.40 per diluted share, compared with $112 million, or $0.49 per share, in 2023. The quarterly loss narrowed, but the full-year loss widened.
Q4 2024 GAAP net loss attributable to common stockholders: $168 million, or $0.41 per diluted share, vs. $289 million, or $0.79, in Q3 2024
Q4 2024 adjusted net loss attributable to common stockholders: $138 million, or $0.34 per diluted share
Full-year 2024 net loss attributable to common stockholders: $1,125 million, or $3.40 per diluted share, vs. $112 million, or $0.49, in 2023
Provision for credit losses fell 55% to $108 million in Q4 2024 from Q3 2024; CET1 capital ratio rose to 11.9%
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.